DaVita Inc. (TRL.F)
- Previous Close
121.60 - Open
123.40 - Bid 123.35 x 14900
- Ask 124.55 x 14800
- Day's Range
123.40 - 123.40 - 52 Week Range
69.24 - 127.80 - Volume
125 - Avg. Volume
28 - Market Cap (intraday)
10.996B - Beta (5Y Monthly) 1.05
- PE Ratio (TTM)
17.81 - EPS (TTM)
6.93 - Earnings Date May 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
143.11
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
www.davita.com70,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: TRL.F
Performance Overview: TRL.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TRL.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TRL.F
Valuation Measures
Market Cap
10.84B
Enterprise Value
20.86B
Trailing P/E
17.53
Forward P/E
14.16
PEG Ratio (5yr expected)
1.16
Price/Sales (ttm)
1.00
Price/Book (mrq)
10.76
Enterprise Value/Revenue
1.72
Enterprise Value/EBITDA
8.99
Financial Highlights
Profitability and Income Statement
Profit Margin
5.70%
Return on Assets (ttm)
5.92%
Return on Equity (ttm)
38.53%
Revenue (ttm)
12.14B
Net Income Avi to Common (ttm)
691.53M
Diluted EPS (ttm)
6.93
Balance Sheet and Cash Flow
Total Cash (mrq)
391.67M
Total Debt/Equity (mrq)
405.21%
Levered Free Cash Flow (ttm)
1.2B
Research Analysis: TRL.F
Company Insights: TRL.F
TRL.F does not have Company Insights